Frontiers in haemodialysis: Innovations and technological advances.

As increasing demand for hemodialysis (HD) treatment incurs significant financial burden to Healthcare systems and ecological burden as well, novel therapeutic approaches as well as innovations and technological advances are being sought that could lead to the development of purification devices such as dialyzers with improved characteristics and wearable technology. Novel knowledge such as the development of more accurate kinetic models, the development of novel HD membranes with the use of nanotechnology, novel manufacturing processes and the latest technology in the science of materials have enabled novel solutions already marketed or on the verge of becoming commercially available. This collaborative paper reviews the latest advances in HD as they were presented by the authors in a recent symposium titled "Frontiers in Haemodialysis", held on 12th December 2019 at the Royal Society of Medicine in London.

[1]  Sarah J. Haigh,et al.  Tunable sieving of ions using graphene oxide membranes. , 2017, Nature nanotechnology.

[2]  F. Casino,et al.  The equivalent renal urea clearance: a new parameter to assess dialysis dose. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  A. K. Vinnikova,et al.  Efficacy and safety of renal tubule cell therapy for acute renal failure. , 2008, Journal of the American Society of Nephrology : JASN.

[4]  A. Martínez‐Castelao,et al.  High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. , 2013, Journal of the American Society of Nephrology : JASN.

[5]  C. Basile,et al.  A user-friendly tool for incremental haemodialysis prescription , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  D. Stamatialis,et al.  In vitro assessment of mixed matrix hemodialysis membrane for achieving endotoxin-free dialysate combined with high removal of uremic toxins from human plasma. , 2019, Acta biomaterialia.

[7]  Salim Mujais,et al.  Haemodialysis membranes , 1994, The Lancet.

[8]  M J Lysaght,et al.  Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis. , 1999, Kidney international.

[9]  D. Stamatialis,et al.  Upscaling of a living membrane for bioartificial kidney device. , 2016, European journal of pharmacology.

[10]  Raymond Vanholder,et al.  Review on uremic toxins: classification, concentration, and interindividual variability. , 2003, Kidney international.

[11]  C Ronco,et al.  Nanoscale Modulation of the Pore Dimensions, Size Distribution and Structure of a new Polysulfone-Based High-Flux Dialysis Membrane , 2001, The International journal of artificial organs.

[12]  I. V. Grigorieva,et al.  Precise and Ultrafast Molecular Sieving Through Graphene Oxide Membranes , 2014, Science.

[13]  M. Rocco,et al.  Effect of frequent hemodialysis on residual kidney function. , 2013, Kidney international.

[14]  V. Kravets,et al.  Electrically controlled water permeation through graphene oxide membranes , 2018, Nature.

[15]  E. Hur,et al.  Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  K. Kalantar-Zadeh,et al.  Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling , 2017, Journal of Nephrology.

[17]  D. Stamatialis,et al.  Development of a living membrane comprising a functional human renal proximal tubule cell monolayer on polyethersulfone polymeric membrane. , 2015, Acta biomaterialia.

[18]  J. Himmelfarb,et al.  A wearable artificial kidney for patients with end-stage renal disease. , 2016, JCI insight.

[19]  D. Marcelli,et al.  High-volume postdilution hemodiafiltration is a feasible option in routine clinical practice , 2014, Artificial organs.

[20]  E. Montagud-Marrahi,et al.  High-permeability alternatives to current dialyzers performing both high-flux hemodialysis and postdilution online hemodiafiltration. , 2019, Artificial organs.

[21]  F. A. Mahomed,et al.  On the Pathology of Uræmia and the Socalled Uræmic Convulsions* , 1877 .

[22]  J. L. Lerma,et al.  IHDIP: a controlled randomized trial to assess the security and effectiveness of the incremental hemodialysis in incident patients , 2019, BMC Nephrology.

[23]  F. Port,et al.  Dose of dialysis: key lessons from major observational studies and clinical trials. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  C. Basile,et al.  Incremental haemodialysis and residual kidney function: more and more observations but no trials. , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  M. Bots,et al.  Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. , 2012, Journal of the American Society of Nephrology : JASN.

[26]  T. Wilt,et al.  KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  Kwang S. Kim,et al.  Noncovalent Functionalization of Graphene and Graphene Oxide for Energy Materials, Biosensing, Catalytic, and Biomedical Applications. , 2016, Chemical reviews.

[28]  M. Hulko,et al.  In Vitro Dialysis of Cytokine‐Rich Plasma With High and Medium Cut‐Off Membranes Reduces Its Procalcific Activity , 2017, Artificial organs.

[29]  Kostas Kostarelos,et al.  Covalent chemical functionalization enhances the biodegradation of graphene oxide , 2017, 2D Materials.

[30]  F. Valerio,et al.  Incremental peritoneal dialysis: a 10 year single-centre experience , 2016, Journal of Nephrology.

[31]  L. G. Vu,et al.  Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.

[32]  Clinical practice guidelines for peritoneal dialysis adequacy. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  In S. Kim,et al.  Tunable Ion Sieving of Graphene Membranes through the Control of Nitrogen-Bonding Configuration. , 2018, Nano letters.

[34]  angesichts der Corona-Pandemie,et al.  UPDATE , 1973, The Lancet.

[35]  P Aebischer,et al.  The bioartificial kidney: progress towards an ultrafiltration device with renal epithelial cells processing. , 1987, Life support systems : the journal of the European Society for Artificial Organs.

[36]  Maurizio Prato,et al.  Biocompatibility and biodegradability of 2D materials: graphene and beyond. , 2019, Chemical communications.

[37]  Pedro M. Baptista,et al.  Bioengineering Organs for Blood Detoxification , 2018, Advanced healthcare materials.

[38]  A. Davenport,et al.  Beta2-microglobulin and phosphate clearances using a wearable artificial kidney: a pilot study. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  F. Wieringa,et al.  The Kidney Health Initiative innovation roadmap for renal replacement therapies: Building the yellow brick road, while updating the map. , 2020, Artificial organs.

[40]  M. Woodward,et al.  Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[41]  D. Stamatialis,et al.  New low-flux mixed matrix membranes that offer superior removal of protein-bound toxins from human plasma , 2016, Scientific Reports.

[42]  E. Gulari,et al.  Design Engineering of a Bioartificial Renal Tubule Cell Therapy Device , 1999, Cell transplantation.

[43]  NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. National Kidney Foundation. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  J. Kong,et al.  Nanoporous Atomically Thin Graphene Membranes for Desalting and Dialysis Applications , 2017, Advanced materials.

[45]  Andrew Davenport,et al.  A wearable haemodialysis device for patients with end-stage renal failure: a pilot study , 2007, The Lancet.

[46]  C. Basile,et al.  The variable target model: a paradigm shift in the incremental haemodialysis prescription , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.